CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Hyperbaric Oxygen TherapyWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D007239 Infection NIH 0.06

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection

Patients who meet inclusion criteria will be randomized into treatment vs control group. Treatment groups will undergo Hyperbaric Oxygen Therapy (HBOT) and compared to the control group.

NCT04343183 COVID-19 Device: Hyperbaric Oxygen Therapy
MeSH:Infection

Primary Outcomes

Description: Compare rates of intubation between treatment and control groups

Measure: Decrease incidence of intubation by 30% or greater

Time: one month

Secondary Outcomes

Description: Measure Glomerular Filtration Rate (GFR) and compare between treatment and control groups

Measure: Decrease renal injury

Time: one month


No related HPO nodes (Using clinical trials)